BACKGROUND: Palliative care has been associated with improved survival and quality of life, with lower rate of end-of-life health care utilization and cost. We examined trends in palliative care utilization in older pancreatic cancer patients. METHODS: Pancreatic cancer patients with and without palliative care consults were identified using the Surveillance, Epidemiology, and End Results (SEER)-Medicare linked database between 2000 and 2009. Trend of palliative care use was studied. Emergency room/intensive care unit (ICU) utilization and costs in the last 30 days of life were compared between both groups using propensity score-matched (PSM) analysis. RESULTS: Of the 54,130 patients, 3,166 (5.8%) received palliative care and 70% received it in the last 30 days of life. The proportion of patients receiving palliative care increased from 1.4% in 2000 to 7.4% in 2009 (P<0.001). Patients with palliative care were more likely to be older, Asian and women. In the unmatched and PSM population, the average visits to the ER in the last 30 days of life were significantly higher for patients who received palliative care, and had a significantly higher cost of care. Similarly, ICU length of stay in the last 30 days of life was higher in patients who did not receive palliative care in both PSM and unmatched patients. Cost of care and number of ICU admissions were not different between palliative and non-palliative care groups in PSM and unmatched patients. CONCLUSIONS: In this study of Medicare patients with pancreatic cancer, palliative care use has increased between 2000 and 2009. Palliative care was largely offered close to the end of life and was not associated with reduced health care utilization or cost.
BACKGROUND: Palliative care has been associated with improved survival and quality of life, with lower rate of end-of-life health care utilization and cost. We examined trends in palliative care utilization in older pancreatic cancer patients. METHODS: Pancreatic cancer patients with and without palliative care consults were identified using the Surveillance, Epidemiology, and End Results (SEER)-Medicare linked database between 2000 and 2009. Trend of palliative care use was studied. Emergency room/intensive care unit (ICU) utilization and costs in the last 30 days of life were compared between both groups using propensity score-matched (PSM) analysis. RESULTS: Of the 54,130 patients, 3,166 (5.8%) received palliative care and 70% received it in the last 30 days of life. The proportion of patients receiving palliative care increased from 1.4% in 2000 to 7.4% in 2009 (P<0.001). Patients with palliative care were more likely to be older, Asian and women. In the unmatched and PSM population, the average visits to the ER in the last 30 days of life were significantly higher for patients who received palliative care, and had a significantly higher cost of care. Similarly, ICU length of stay in the last 30 days of life was higher in patients who did not receive palliative care in both PSM and unmatched patients. Cost of care and number of ICU admissions were not different between palliative and non-palliative care groups in PSM and unmatched patients. CONCLUSIONS: In this study of Medicare patients with pancreatic cancer, palliative care use has increased between 2000 and 2009. Palliative care was largely offered close to the end of life and was not associated with reduced health care utilization or cost.
Entities:
Keywords:
Palliative care; cost of care; emergency room; end-of-life; intensive care unit (ICU); pancreatic cancer
Authors: Eric J Roeland; Daniel P Triplett; Rayna K Matsuno; Isabel J Boero; Lindsay Hwang; Heidi N Yeung; Loren Mell; James D Murphy Journal: J Natl Compr Canc Netw Date: 2016-04 Impact factor: 11.908
Authors: Thomas Bramley; Vincent Antao; Orsolya Lunacsek; Kristin Hennenfent; Anthony Masaquel Journal: J Med Econ Date: 2016-06-17 Impact factor: 2.448
Authors: Betty R Ferrell; Jennifer S Temel; Sarah Temin; Erin R Alesi; Tracy A Balboni; Ethan M Basch; Janice I Firn; Judith A Paice; Jeffrey M Peppercorn; Tanyanika Phillips; Ellen L Stovall; Camilla Zimmermann; Thomas J Smith Journal: J Clin Oncol Date: 2016-10-28 Impact factor: 44.544
Authors: Sandhya Yadav; Isaac W Heller; Nancy Schaefer; Ramzi G Salloum; Sheri M Kittelson; Diana J Wilkie; Jinhai Huo Journal: Support Care Cancer Date: 2020-05-21 Impact factor: 3.603
Authors: Nadia N Khan; Tennille Lewin; Amy Hatton; Charles Pilgrim; Liane Ioannou; Luc Te Marvelde; John Zalcberg; Sue Evans Journal: Am J Cancer Res Date: 2022-02-15 Impact factor: 6.166
Authors: Mellar P Davis; Erin A Vanenkevort; Alexander Elder; Amanda Young; Irina D Correa Ordonez; Mark J Wojtowicz; Halle Ellison; Carlos Fernandez; Zankhana Mehta; Bertrand Behm; Glen Digwood; Rajiv Panikkar Journal: Support Care Cancer Date: 2022-03-15 Impact factor: 3.603
Authors: Paige E Sheridan; Wendi G LeBrett; Daniel P Triplett; Eric J Roeland; Andrew R Bruggeman; Heidi N Yeung; James D Murphy Journal: Am J Hosp Palliat Care Date: 2021-01-11 Impact factor: 2.090
Authors: Jack Bevins; Nizar Bhulani; Suleyman Y Goksu; Nina N Sanford; Ang Gao; Chul Ahn; Mary E Paulk; Stephanie Terauchi; Sandi L Pruitt; Anna Tavakkoli; Ramona L Rhodes; Syed M A Kazmi; Muhammad S Beg Journal: Am J Clin Oncol Date: 2021-05-01 Impact factor: 2.787
Authors: Vinay B Rao; Emmanuelle Belanger; Pamela C Egan; Thomas W LeBlanc; Adam J Olszewski Journal: J Palliat Med Date: 2020-06-29 Impact factor: 2.947
Authors: Angela C Tramontano; Yufan Chen; Tina R Watson; Andrew Eckel; Deirdre F Sheehan; Mary Linton B Peters; Pari V Pandharipande; Chin Hur; Chung Yin Kong Journal: Medicine (Baltimore) Date: 2019-12 Impact factor: 1.889
Authors: Karen J Ortiz-Ortiz; Guillermo Tortolero-Luna; Carlos R Torres-Cintrón; Diego E Zavala-Zegarra; Axel Gierbolini-Bermúdez; María R Ramos-Fernández Journal: JCO Oncol Pract Date: 2021-02